Page last updated: 2024-09-03

gefitinib and bp-1-102

gefitinib has been researched along with bp-1-102 in 1 studies

Compound Research Comparison

Studies
(gefitinib)
Trials
(gefitinib)
Recent Studies (post-2010)
(gefitinib)
Studies
(bp-1-102)
Trials
(bp-1-102)
Recent Studies (post-2010) (bp-1-102)
5,2315662,91933032

Protein Interaction Comparison

ProteinTaxonomygefitinib (IC50)bp-1-102 (IC50)
Signal transducer and activator of transcription 3Homo sapiens (human)6.8
Signal transducer and activator of transcription 3 Mus musculus (house mouse)6.8

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, Y; Kong, L; Li, C; Li, S; Lin, JY; Liu, M; Luo, J; Sun, H; Xia, Y; Yang, L; Yu, K; Yu, W; Zhang, W1

Other Studies

1 other study(ies) available for gefitinib and bp-1-102

ArticleYear
Discovery of an Orally Selective Inhibitor of Signal Transducer and Activator of Transcription 3 Using Advanced Multiple Ligand Simultaneous Docking.
    Journal of medicinal chemistry, 2017, 04-13, Volume: 60, Issue:7

    Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast; Breast Neoplasms; Cell Line; Cell Line, Tumor; Female; Humans; MCF-7 Cells; Mice, Inbred ICR; Mice, Nude; Molecular Docking Simulation; Rats; STAT3 Transcription Factor

2017